One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is a paper indexed in ScholarIQ from OpenAlex.
How many citations does One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases have?
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases has 32 citations in the OpenAlex counts ScholarIQ stores.
When was One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases published?
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases has 2020 year in the ScholarIQ index.
What is the open-access status of One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases has green oa status in the ScholarIQ index.
What is the DOI of One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?
The DOI for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is on the source record.
What is the PMID of One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?
The PMID for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is on the source record.
What is the OpenAlex record for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases?
The OpenAlex for One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases is on the source record.